Relative Bioavailability of Zongertinib, an Orally Administered HER2-Selective Tyrosine Kinase Inhibitor, under Fed and Fasted Conditions in Healthy Male Participants: Results from Two Randomized, Open-Label, Crossover Studies
在健康男性受试者中,口服HER2选择性酪氨酸激酶抑制剂Zongertinib在空腹和进食状态下的相对生物利用度:两项随机、开放标签、交叉研究的结果
期刊:Molecular Pharmaceutics
影响因子:4.5
doi:10.1021/acs.molpharmaceut.5c00832
Pereira, Hélène; Wölke, Stefan; Sadrolhefazi, Behbood; Esmaeili, Habib; Wind, Sven; Gan, Guanfa; Müller, Fabian; Minich, David; Bader, Kerstin; Grempler, Rolf; Law, Yeuk Ki; Roessner, Philipp M